Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Saunders

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Ecology and Evolution|September 15, 2017
Phenology of brown marmorated stink bug described using female reproductive developmentAnne L Nielsen, Shelby Fleischer, George C Hamilton, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2010
CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cellsSven Jähnichen, Christophe Blanchetot, David Maussang, et al.
Plos One|April 13, 2011
Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral moleculesAnna Hultberg, Nigel J Temperton, Valérie Rosseels, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2012
Lead optimization of purine based orally bioavailable Mps1 (TTK) inhibitorsD Vijay Kumar, Christophe Hoarau, Matthew Bursavich, et al.
Science Translational Medicine|April 24, 2015
Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivoJulia Cuende, Stéphanie Liénart, Olivier Dedobbeleer, et al.
Molecular Cancer Therapeutics|May 31, 2013
Pharmacologic activation of PKM2 slows lung tumor xenograft growthK Mark Parnell, Jason M Foulks, Rebecca N Nix, et al.
Cancer Research|July 5, 2015
Depleting MET-Expressing Tumor Cells by ADCC Provides a Therapeutic Advantage over Inhibiting HGF/MET SignalingAnna Hultberg, Virginia Morello, Leander Huyghe, et al.
Science (New York, N.Y.)|May 25, 2019
Protein crystallization promotes type 2 immunity and is reversible by antibody treatmentEmma K Persson, Kenneth Verstraete, Ines Heyndrickx, et al.
Nature Communications|September 12, 2020
Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancerGrégoire de Streel, Charlotte Bertrand, Nicolas Chalon, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2011
Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersMona Bafadhel, Susan McKenna, Sarah Terry, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Ecology and Evolution|September 15, 2017
Phenology of brown marmorated stink bug described using female reproductive developmentAnne L Nielsen, Shelby Fleischer, George C Hamilton, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2010
CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cellsSven Jähnichen, Christophe Blanchetot, David Maussang, et al.
Plos One|April 13, 2011
Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral moleculesAnna Hultberg, Nigel J Temperton, Valérie Rosseels, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2012
Lead optimization of purine based orally bioavailable Mps1 (TTK) inhibitorsD Vijay Kumar, Christophe Hoarau, Matthew Bursavich, et al.
Science Translational Medicine|April 24, 2015
Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivoJulia Cuende, Stéphanie Liénart, Olivier Dedobbeleer, et al.
Molecular Cancer Therapeutics|May 31, 2013
Pharmacologic activation of PKM2 slows lung tumor xenograft growthK Mark Parnell, Jason M Foulks, Rebecca N Nix, et al.
Cancer Research|July 5, 2015
Depleting MET-Expressing Tumor Cells by ADCC Provides a Therapeutic Advantage over Inhibiting HGF/MET SignalingAnna Hultberg, Virginia Morello, Leander Huyghe, et al.
Science (New York, N.Y.)|May 25, 2019
Protein crystallization promotes type 2 immunity and is reversible by antibody treatmentEmma K Persson, Kenneth Verstraete, Ines Heyndrickx, et al.
Nature Communications|September 12, 2020
Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancerGrégoire de Streel, Charlotte Bertrand, Nicolas Chalon, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2011
Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersMona Bafadhel, Susan McKenna, Sarah Terry, et al.
Pageof 9